Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy
The DOI matches its Crossref record; 218 of the 218 references it cites were found in a registry or an index.
Abstract
The BCL-2 protein family determines the commitment of cells to apoptosis, an ancient cell suicide programme that is essential for development, tissue homeostasis and immunity. Too little apoptosis can promote cancer and autoimmune diseases; too much apoptosis can augment ischaemic conditions and drive neurodegeneration. We discuss the biochemical, structural and genetic studies that have clarified how the interplay between members of the BCL-2 family on mitochondria sets the apoptotic threshold. These mechanistic insights into the functions of the BCL-2 family are illuminating the physiological control of apoptosis, the pathological consequences of its dysregulation and the promising search for novel cancer therapies that target the BCL-2 family.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Together with BOK, BCL2 family apoptosis regulator (BOK) [47], BAX and BAK are the only BCL2 family members characterized so far in mammalian cells for their ability to form pores across the outer mitochondrial membrane (OMM) and possibly other intracellular membranes [29, 42, 43].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [29]
In the citing paper
“which is controlled by pro-apoptotic and anti-apoptotic members of the BCL2, apoptosis regulator (BCL2) protein family, a group of proteins sharing one to four BCL2 homology (BH) domains (i.e., BH1, BH2, BH3, and BH4) [29, 42, 43].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [29]
In the citing paper
“Intrinsic apoptosis is a form of RCD initiated by a variety of microenvironmental perturbations including (but not limited to) growth factor withdrawal, DNA damage, endoplasmic reticulum (ER) stress, reactive oxygen species (ROS) overload, replication stress, microtubular alterations or mitotic defects [29–34].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [29]
In the citing paper
“MOMP is antagonized by anti-apoptotic members of the BCL2 family, including BCL2 itself, BCL2 like 1 (BCL2L1; best known as BCL-XL), MCL1, BCL2 family apoptosis regulator (MCL1), BCL2 like 2 (BCL2L2; best known as BCL-W), and BCL2 related protein A1 (BCL2A1; best known—in human—as BFL-1) [29, 42, 43].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [29]
In the citing paper
“Thus, most pro-survival BCL2 family members inhibit BAX and BAK by preventing their oligomerization and pore-forming activity either directly, upon physical sequestration at the OMM, or indirectly, following the sequestration of BH3-only activators [29, 64, 79, 110].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [29]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Items 201–218 of 218
Suppression of B-cell lymphomagenesis by the BH3-only proteins Bmf and Bad
Frenzel, A., Labi, V., Chmelewskij, W., Ploner, C., Geley, S., Fiegl, H., Tzankov, A., & Villunger, A. (2009) · Blood · doi:10.1182/blood-2009-03-212670 · Cited by 68
The Bcl-2 Family Antagonist ABT-737 Significantly Inhibits Multiple Animal Models of Autoimmunity
Bardwell, P. D., Gu, J., McCarthy, D., Wallace, C., Bryant, S., Goess, C., Mathieu, S., Grinnell, C., Erickson, J., Rosenberg, S. H., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802813 · Cited by 67
Ottina, E., Grespi, F., Tischner, D., Soratroi, C., Geley, S., Ploner, A., Reichardt, H. M., Villunger, A., & Herold, M. J. (2012) · Blood · doi:10.1182/blood-2011-12-399089 · Cited by 61
Discovery and molecular characterization of a Bcl-2–regulated cell death pathway in schistosomes
Lee, E. F., Clarke, O. B., Evangelista, M., Feng, Z., Speed, T. P., Tchoubrieva, E. B., Strasser, A., Kalinna, B. H., Colman, P. M., & Fairlie, W. D. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100652108 · Cited by 57
Self-citationContext-dependent Bcl-2/Bak Interactions Regulate Lymphoid Cell Apoptosis
Dai, H., Meng, X. W., Lee, S. H., Schneider, P. A., & Kaufmann, S. H. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.004770 · Cited by 57
Golstein, P. (1998) · Science · doi:10.1126/science.281.5381.1283 · Cited by 54
Proapoptotic Bak and Bax guard against fatal systemic and organ-specific autoimmune disease
Mason, K. D., Lin, A., Robb, L., Josefsson, E. C., Henley, K. J., Gray, D. H. D., Kile, B. T., Roberts, A. W., Strasser, A., Huang, D. C. S., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1215097110 · Cited by 52
Self-citationPang, Y.-P., Dai, H., Smith, A., Meng, X. W., Schneider, P. A., & Kaufmann, S. H. (2012) · Scientific Reports · doi:10.1038/srep00257 · Cited by 46
Clybouw, C., Mérino, D., Nebl, T., Masson, F., Robati, M., O’Reilly, L. A., Hübner, A., Davis, R. J., Strasser, A., & Bouillet, P. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2011.198 · Cited by 42
Self-citationPeng, R. Y., Tong, J.-S., Li, H., Yue, B., Zou, F., Yu, J., & Zhang, L. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.4 · Cited by 42
BIM-mediated membrane insertion of the BAK pore domain is an essential requirement for apoptosis
Weber, K., Harper, N., Schwabe, J., & Cohen, G. M. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.09.010 · Cited by 41
The structure of Boo/Diva reveals a divergent Bcl-2 protein
Rautureau, G. J. P., Day, C. L., & Hinds, M. G. (2010) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.22728 · Cited by 34
Structure-Based Redesign of the Binding Specificity of Anti-Apoptotic Bcl-xL
Chen, T. S., Palacios, H. H., & Keating, A. E. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2012.11.009 · Cited by 33
BCLW Mediates Survival of Postmitotic Sertoli Cells by Regulating BAX Activity
Ross, A. J., Amy, S. P., Mahar, P. L., Lindsten, T., Knudson, C. M., Thompson, C. B., Korsmeyer, S. J., & MacGregor, G. R. (2001) · Developmental Biology · doi:10.1006/dbio.2001.0445 · Cited by 32
Herold, M. J., Rohrbeck, L., Lang, M. J., Grumont, R. J., Gerondakis, S., Tai, L., Bouillet, P., Kaufmann, T., & Strasser, A. (2013) · EMBO Reports · doi:10.1038/embor.2013.152 · Cited by 28
Self-citationAkhtar, R. S., Klocke, B. J., Strasser, A., & Roth, K. A. (2008) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.2008.951749 · Cited by 26
Self-citationMinor cell-death defects but reduced tumor latency in mice lacking the BH3-only proteins Bad and Bmf
Baumgartner, F., Woess, C., Pedit, V., Tzankov, A., Labi, V., & Villunger, A. (2012) · Oncogene · doi:10.1038/onc.2012.78 · Cited by 18
NMR structure of a phosphatidyl‐ethanolamine binding protein from Drosophila
Rautureau, G. J. P., Vovelle, F., Schoentgen, F., Decoville, M., Locker, D., Damblon, C., & Jouvensal, L. (2009) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.22682 · Cited by 9
Cited by
Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680
“MOMP is antagonized by anti-apoptotic members of the BCL2 family, including BCL2 itself, BCL2 like 1 (BCL2L1; best known as BCL-XL), MCL1, BCL2 family apoptosis regulator (MCL1), BCL2 like 2 (BCL2L2; best known as BCL-W), and BCL2 related protein A1 (BCL2A1; best known—in human—as BFL-1) [29, 42, 43].”
BackgroundSelf-citationThe molecular machinery of regulated cell death
Tang, D., Kang, R., Berghe, T. V., Vandenabeele, P., & Kroemer, G. (2019) · Cell Research · doi:10.1038/s41422-019-0164-5 · Cited by 2,549
Targeting apoptosis in cancer therapy
Carneiro, B. A., & El-Deiry, W. S. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0341-y · Cited by 2,542
Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins
Singh, R., Letai, A., & Sarosiek, K. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0089-8 · Cited by 2,111
Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice
Chang, J., Wang, Y., Shao, L., Laberge, R.-M., Demaria, M., Campisi, J., Janakiraman, K., Sharpless, N. E., Ding, S., Feng, W., et al. (2016) · Nature Medicine · doi:10.1038/nm.4010 · Cited by 1,819
Metadata
- Authors
- Czabotar, P. E., Lessene, G., Strasser, A., & Adams, J. M.
- Affiliations
- The University of Melbourne (AU)
- Corresponding author
- Strasser, Andreas
- Adams, Jerry M.
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2013-12-20
- Volume
- 15
- Issue
- 1
- Pages
- 49-63
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W2088883749
- Cited by
- 3,219
- References
- 218
- Citations by year
- 2026: 164 · 2025: 220 · 2024: 249 · 2023: 230 · 2022: 265 · 2021: 319 · 2020: 299 · 2019: 285 · 2018: 314 · 2017: 292 · 2016: 287 · 2015: 209 · 2014: 77 · 2013: 1
- FWCI
- 18.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- Bcl-2 family proteins, apoptosis, mitochondrial outer membrane, BCL-2 inhibitor, cancer therapy, autoimmune disease, neurodegeneration, ischemia, apoptosis regulation
- MeSH terms
- Amino Acid Sequence, Animals, Humans, Models, Molecular, Molecular Sequence Data, Neoplasms, Signal Transduction, Apoptosis, Protein Structure, Secondary, Proto-Oncogene Proteins c-bcl-2, Apoptosis Regulatory Proteins, Protein Multimerization, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.